Skip to content
healthcare.dev

Roflumilast

NDC 67877-730, Roflumilast, tablet, from Ascend Laboratories, LLC.

Product NDC
67877-730
Status
Listed
Labeler
Ascend Laboratories, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212490
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67877-730 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ROFLUMILAST250 ug/1

Pharmacologic classes

Phosphodiesterase 4 Inhibitor [EPC]; Phosphodiesterase 4 Inhibitors [MoA]

Package NDCNDC-11Package
67877-730-0567877073005500 TABLET in 1 BOTTLE (67877-730-05)
67877-730-306787707303030 TABLET in 1 BOTTLE (67877-730-30)
67877-730-87678770730871 BLISTER PACK in 1 CARTON (67877-730-87) / 28 TABLET in 1 BLISTER PACK
67877-730-906787707309090 TABLET in 1 BOTTLE (67877-730-90)
67877-730-93678770730934 BLISTER PACK in 1 CARTON (67877-730-93) / 7 TABLET in 1 BLISTER PACK (67877-730-32)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/93d72a99-64dc-4fde-a5b8-78331fa60787
  • NADAC price for package 67877073093

    GET /v1/drugs/nadac/67877073093

Use it

Look up 67877-730 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67877-730 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67877-730. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.